#AntibioticResistance Archives

Non-KPC Characteristics of Novel BL/BLI Compounds in Pseudomonas aeruginosa

By Mourabit Halima 2024.10.17

Editor's Note: In the previous article, we provided a detailed overview of the advancements in the use of novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations in Enterobacterales with various resistance mechanisms. This…

New Characteristics of BL/BLI Compounds Targeting Non-KPC Enterobacterales

By Peter W. PENG 2024.10.16

Editor's Note: As carbapenem-resistant Gram-negative bacteria (CRO) have become increasingly prevalent, the development and application of novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations have gained significant attention from researchers worldwide. A recent…

Application of carbapenems in the treatment of MDR-GNB and management of drug resistance

By Mourabit Halima 2024.10.15

Editor's note: With the increase in multi-drug resistant Gram-negative bacterial infections (MDR-GNB) worldwide, the use strategy of carbapenems as key drugs for the treatment of such infections has received widespread…

Dr. Yonghong Xiao: Responsibilities and Capacity Building of Infectious Disease Physicians

By Lisa Cui 2024.09.22

Editor's Note: In China, the Infectious Diseases Department has existed as an independent clinical department for over half a century, with the primary responsibility of infectious disease physicians being the…